Skip to main content

Round one to DuPont over Chemours in legal battle

6th April 2020

Submitted by:

Andrew Warmington

The first step in ongoing litigation in the US between Chemours and its parent firm DuPont over the cost of environmental liabilities relating to historic pollution caused by per- and polyfluoroalkyl substances (PFASs) went DuPont’s way on 2 April. Chemours has said that it will appeal to the Delaware Supreme Court.

Delaware judge Sam Glasscock III granted DuPont’s request to dismiss a lawsuit, saying that he had no jurisdiction to hear the case because the separation agreement between the companies clearly states that all disputes arising from the spin-off are subject to binding arbitration. Arbitrators, unlike the courts, are not able to make significant changes to the agreement.

DuPont spun off Chemours, its former Performance Chemicals unit, in 2015. At the time, it was facing multiple personal injury lawsuits as a result of exposure to perfluorooctanoic acid (PFOA). Its liability was capped at $128 million, though it eventually agreed to pay half of the settlement amount of  $671 million and up to $125 million more toward costs of other PFOA-related litigation.

In 2019, Chemours sued DuPont, claiming that it deliberately and knowingly understated the likely cost of historic liabilities by $1-2 billion. At one North Carolina factory alone, these exceed DuPont’s estimate 100-fold. Potential costs have since mushroomed as a result of new lawsuits over water contamination related to PFAS chemicals, as well as PFOA and the GenX fluorosurfactant.

Chemours also sought a judgment limiting DuPont's indemnification rights to the maximum liabilities it certified or for the $3.9 billion dividend it had paid DuPont to be repaid. It argued that the separation agreement was forced upon it. While it was signed by the Chemours board of the time, the company said, this comprised three DuPont executives who had all resigned by the time the spin-off was completed.

However, Judge Glasscock established that these actions were legal and that Nigel Pond, VP at the time, “executed the Separation Agreement on behalf of Chemours”. He also dismissed the claim that DuPont’s domination of the negotiations meant that mutual consent was not properly given.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington